ArticlePediatric blood & cancer2014

Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.

Heidi Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.